Experiences of recruiting to a pilot trial of Cardiac Rehabilitation In patients with Bowel cancer (CRIB) with an embedded process evaluation : lessons learned to improve recruitment by Hubbard, Gill et al.
Hubbard et al. Pilot and Feasibility Studies  (2015) 1:15 
DOI 10.1186/s40814-015-0009-zRESEARCH Open AccessExperiences of recruiting to a pilot trial of Cardiac
Rehabilitation In patients with Bowel cancer
(CRIB) with an embedded process evaluation:
lessons learned to improve recruitment
Gill Hubbard1*, Anna Campbell2, Zoe Davies3, Julie Munro1, Aileen V Ireland4, Stephen Leslie5, Angus JM Watson6,7
and Shaun Treweek8Abstract
Background: Recruitment to randomised controlled trials (RCTs) is a perennial problem. Calls have been made for
trialists to make recruitment performance publicly available. This article presents our experience of recruiting to a
pilot RCT of cardiac rehabilitation for patients with bowel cancer with an embedded process evaluation.
Methods: Recruitment took place at three UK hospitals. Recruitment figures were based on the following: i) estimated
number of patient admissions, ii) number of patients likely to meet inclusion criteria from clinician input and
iii) recruitment rates in previous studies. The following recruitment procedure was used:
1. Nurse assessed patients for eligibility.
2. Patients signed a screening form indicating interest in and agreement to be approached by a researcher
about the study.
3. An appointment was made at which the patient signed a consent form and was randomised to the
intervention or control group.
Information about all patients considered for the study and subsequently included or excluded at each stage of
the recruitment process and reasons given were recorded.
Results: There were variations in the time taken to award Research Management approval to run the study at the
three sites (45–359 days). Sixty-two percent of the original recruitment estimate was reached. The main reason for
under-recruitment was due to over-estimation of the number of patient admissions; other reasons were i) not assessing
all patients for eligibility, ii) not completing a screening form for eligible patients and iii) patients who signed a
screening form being lost to the study before consenting and randomisation.
Conclusions: Pilot trials should not simply aim to improve recruitment estimates but should also identify factors likely
to influence recruitment performance in a future trial and inform the development of that trial’s recruitment strategies.
Pilot trials are a crucial part of RCT design. Nevertheless, pilot trials are likely to be small scale, involving only a small
number of sites, and contextual differences between sites are likely to impact recruitment performance in any future
trial. This means that ongoing monitoring and evaluation in trials are likely to be required.
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The randomised controlled trial (RCT) is seen as the
gold standard research design when evaluating effective-
ness of healthcare interventions [1]. RCTs that fail to
recruit, however, may not yield reliable evidence. Under-
powered studies are more likely to go unpublished or re-
port statistically non-significant results, which increases
the chances of the abandonment of interventions with
potentially clinically important effects [2-4]. There are
several other possible consequences arising from poor
recruitment, such as increasing the cost and workload of
the trial itself and ethical implications associated with
recruiting patients to a trial that will ultimately fail to
answer its research question [2-4].
Poor recruitment has plagued RCTs for decades
[5-10], suggesting that there is no ‘quick fix’ or ‘magic
solution’ to the problem [4]. A review of UK publicly
funded multicentre trials (2002–2008) found that just
over half of trials recruited their originally specified tar-
get sample size, just over three quarters recruited 80% of
their target and just under half of trials received an ex-
tension of some kind [11]. Trial registries have improved
transparency about the number of trials meeting recruit-
ment targets but fail to capture the reasons for success-
ful or poor recruitment, making them of limited use for
understanding and addressing recruitment challenges
[12]. Considerable effort has, however, been made to
understand the reasons for poor or slow recruitment,
and research on this subject indicates a multitude of
system- and individual-level factors [13-19].
System-level factors include research governance proce-
dures that have added to the complexity of trial procedures
and as a consequence have seriously delayed recruit-
ment [17,20,21]. Ironically, recruitment delays have
arisen when protocol amendments to improve recruit-
ment rates have been submitted to research and ethical
committees for approval [16,21]. The influence of culture
and context on recruitment is less well understood but
will include factors such as the research infrastructure at
the location where recruitment is taking place [22].
More attention has been given to individual-level fac-
tors. Given the importance of clinicians in the recruit-
ment process, particular attention has been paid to
understanding clinician-level factors [14,16,23-27]. Clin-
ician barriers to recruiting patients include lack of time,
lack of research experience and training, concerns about
the impact of the trial on the doctor-patient relationship
and concerns about the extra burden on patients [14,16].
Similarly, substantial effort has been made to understand
patient-level factors [19,25,26,28-30]. Commonly re-
ported patient barriers include dislike of randomisation,
existing preference for a particular treatment, distrust of
research and fear that involvement will negatively impact
on the relationship with their doctor [17,31]. Trialistshave attempted to address these barriers to recruitment,
although systematic reviews of studies evaluating inter-
ventions to increase recruitment to RCTs suggest that
few interventions have a solid evidence base [2,4,32-34].
In order to contribute towards addressing the problem
of recruitment, calls have been made for trialists to pub-
lish their experiences of recruitment and to make data
regarding recruitment performance publicly available
[1,20,35]. This article presents our experience of
recruiting to a pilot RCT of cardiac rehabilitation for
patients with bowel cancer [36]. Key aims of the pilot
trial were to determine eligibility, consent, recruitment
and retention rates in preparation for a future large-
scale effectiveness RCT. Our findings may be of use to




Data were drawn from the Cardiac Rehabilitation In
Bowel cancer patients (CRIB) pilot trial, the design of
which is described elsewhere [36]. Briefly, CRIB is a two-
arm pilot RCT to assess the effectiveness of cardiac re-
habilitation on bowel cancer patients’ level of physical
activity, quality of life, fatigue, anxiety and depression
compared to patients in the control arm receiving the
‘Staying healthy after bowel cancer’ booklet produced by
Bowel Cancer UK, which includes a section on ‘staying
fit’ [37]. This paper reports the analysis of recruitment
data for this pilot trial.
Recruitment setting
Recruitment took place at three UK hospitals where pa-
tients with bowel cancer were admitted for surgery and
where cardiac rehabilitation is also available on the site.
Site 1 included patients who lived in remote and rural
areas where access to services such as cardiac rehabilita-




1. Adults who have been diagnosed with primary
colorectal cancer and are in the recovery period
post-surgery.
2. Patients receiving adjunctive chemotherapy/
radiotherapy are included. Patients must wait 48 h
post-chemotherapy before taking part in the
intervention.
Exclusion
1. Patients with advanced disease.
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rehabilitation and are deemed unsafe to participate
in exercise classes. (According to recent guidelines,
those with severe anaemia should delay exercise and
patients with compromised immune function should
avoid public gyms and exercise classes [40]).
3. Patients with severe cognitive impairment and who
therefore are unable to give informed consent to
participate in the study, or are unable to
communicate in English as this is the language used
in the delivery of cardiac rehabilitation.
Approvals
An application for National Health Service (NHS) ethics
approval was submitted using the electronic Integrated
Research Application System (IRAS) [41]. Applications
for NHS Research Management approval, an additional
approval required in the UK for research involving NHS
patients, staff or premises, were made to the Research
and Development office in each of the three Health
Boards conducting the study.
Sample size estimation
The aim of our pilot was not to provide a definitive esti-
mate of treatment effect, so we did not have a formal
sample size calculation. Rather, the aim was to provide
robust estimates of the likely rates of recruitment and
retention and to yield estimates of the variability of the
primary and secondary outcomes to inform power calcu-
lations for a future large-scale effectiveness trial. Our re-
cruitment calculation for the pilot trial was based on
three factors:
 Estimated number of patients admitted for surgery
(based on previous annual admissions)
 Number of patients likely to meet inclusion criteria
based on clinician input
 Recruitment rates in previous similar studies (e.g.
trials of physical activity interventions for people
with cancer).
Based on information provided by the local NHS prin-
cipal investigators of the number of patient admissions
in the previous year (2012), we expected 250 patients, in
total, to be admitted for surgery across the three sites
over a 6-month period. Cancer clinicians involved in the
study estimated that approximately one third (n = 83)
would be ineligible, and based on recruitment to an
RCT of physical activity with patients with cancer in
Scotland (27% recruitment rate) [42] and a trial involv-
ing patients with colorectal cancer within 3 months of
completing surgery conducted in Canada (35% recruit-
ment rate) [43], we estimated that just over a third of
eligible patients would consent (n = 66) to take part.Thus, for the pilot RCT, we expected to recruit around
66 patients (40% of eligible patients). We estimated that
sites 2 and 3 would recruit 26 patients, respectively, and
that site 1 would recruit 14 patients, as this site admitted
fewer patients for surgery compared with the other two
sites. These are the recruitment, eligibility and consent
rates that we had in the study protocol that was ap-
proved by the NHS research and ethics committee.
Recruitment and consent
Recruitment took place over 6 months, from 1 January
to 31 July 2014. The recruitment process had several
stages, and at each stage, patients could withdraw. At
sites 1 and 2, the following procedure was followed:
1. A colorectal clinical nurse specialist assessed
patients admitted for surgery for eligibility using
medical notes and knowledge about the patients.
The nurse, using free text, recorded reasons for
ineligibility.
2. Patients who were eligible were given an information
sheet. This took place either pre-or post-surgery on
the ward and was carried out by a clinical nurse
specialist. Screening forms, which were required for
all eligible patients, provided clinical (e.g. date of
surgery, adjuvant treatments) and demographic (e.g.
age, gender) information. Patients signed this form
on the ward if they were interested in participating
and willing to be approached by a researcher about
the study at a later date. The form was also signed
by those who did not wish to participate but who
were willing to have information about them
retained for the purposes of the study (i.e. to evaluate
if recruited patients were representative of eligible
patients). If a screening form was not completed, then
the patient was lost to the study.
3. A researcher contacted each patient who signed a
screening form indicating willingness to participate
in the study by telephone, and they were given
further information about the study. An appointment
was made at which the patient signed a consent form
and was randomised to the intervention or control
group.
Recruitment at site 3 was slightly different because a re-
search nurse carried out all three stages of the recruitment
process as opposed to the combined effort of nurses and a
researcher. Research nurses are nurses employed by hospi-
tals in the UK to recruit to RCTs and can be working on a
large number of trials simultaneously.
Data collection and analysis
Recruitment performance was closely monitored and
discussed at a monthly meeting by the three researchers
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form included the following information: date of surgery,
cancer diagnosis (Dukes or AJCC-TNM staging), type of
surgery, method of surgery, type of stoma (if applicable),
type of adjuvant therapy (if any) and inclusion and ex-
clusion criteria. These data were entered into the Open-
Clinica (https://www.openclinica.com) data management
system developed by Tayside Clinical Trials Unit for the
study. The database also included the following fields: if
patient was given information sheet; patient permission
OR reason for not taking part. Free text was used by
nurses, research nurses and researchers involved in the
recruitment process to describe reasons why eligible pa-
tients did not wish to participate, which, for the purpose
of analysis, were sorted into one of seven categories:
 No longer eligible
 Distance/travel
 Stated that they are currently exercising and fit
 Clinical (e.g. poor recovery from surgery, receiving
adjuvant therapy, co-morbidity)
 Too much of a commitment
 Not/no longer interested
 No reason given.
Thus, information about all patients considered for the
study and subsequently included or excluded at each
stage of the recruitment process and reasons given were
recorded. Aggregated descriptive presentations of re-
cruitment data for all sites and for each of the three sites
were made and reported below.
Results
Approvals
An application for NHS ethical approval was submitted
12 months prior to the planned recruitment start date
(January 2014). The submission was made on 20 January
2013, received by the NHS ethical committee on 25
January and reviewed by the committee at a meeting on
14 February 2013 (REC reference 13/NS/0004; IRAS
project ID 121757). The committee requested further in-
formation and submission of revised documentation.
This request was submitted to the Chair of the ethical
committee on 21 February 2013, and a favourable ethical
opinion was given on 22 February 2013.
NHS Research Management approval was sought from
each of the three sites at the same time as NHS ethics
committee approval was sought, which is normal prac-
tice in the UK. There were substantial variations in the
time taken to award Research Management approval to
run the study at the three sites:
 Site 1: 05 March 2013 (45 days)
 Site 2: 17 December 2013 (331 days) Site 3: 14 January 2014 (359 days).
There are three main reasons to account for this vari-
ation. Firstly, the request for Research Management ap-
proval was not directed to the correct person in the
Research Office at site 3 and was not dealt with until the
correct person got the application for approval several
months after the application was submitted. Chasing an
application at a distance by email and telephone proved
difficult and caused delays. Secondly, the information re-
quested by research managers across the sites differed,
although all three sites were approving the same piece of
research. For instance, the research manager at site 2
insisted that the contract between the universities
employing the co-applicants on the grant be signed be-
fore giving approval. This was not required at the other
two sites. Third, the principal investigator for the study
was based at site 1 and had local contacts in the NHS
Research Office, which may have contributed towards
quickly obtaining approval.
Original estimated and actual recruitment rates
Figure 1 shows patient flow throughout the study.
In total, 41 patients were recruited to the study, which
is 62% of our original estimate of 66 recruited patients.
Table 1 shows the difference between estimated and ac-
tual patient admissions, eligibility and consent rates
across all three sites. Figure 1 shows graphically the dif-
ference between estimated and actual patient admissions
at each stage of the recruitment process.
The number of actual surgical admissions was lower
than expected (198 vs 250). We correctly estimated the
proportion of patient admissions that would be eligible
(i.e. approximately two thirds); 133 out of 198 actual pa-
tient admissions were judged as eligible for the study
(67%). However, because we had initially over-estimated
the number of patient admissions, there was a difference
of 20% between expected and actual number of eligible
patients. We estimated that 66 patients would consent
to study participation and be randomised. Seventy-four
patients signed a screening form indicating that they
were interested in participating (see Table 2), but only 41
of these patients were actually randomised into the
study. Thirty-one percent as opposed to an estimated
40% of eligible patients were randomised.
Revised estimated and actual recruitment rates
Before recruitment actually started, recruitment esti-
mates were revised by nurses involved in recruitment in
each site using records of the number of patients admitted
for surgery in the previous year (2012). The reason for
requesting a revised figure was to obtain an estimate from
those clinicians who would be actually involved in recruit-
ment, using their records. Table 1 shows the difference
Figure 1 Recruitment flowchart.
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eligibility and consent rates in each site. Figures 2, 3, 4
and 5 show graphically the difference between revised es-
timated and actual patient admissions at each stage of the
recruitment process in each site.
Table 1 and Figures 2, 3, 4 and 5 show that all sites
over-estimated the number of patient admissions. The
main reason why we did not meet our recruitment target
was due to over-estimation of the number of patient ad-
missions in all sites. However, all sites achieved the esti-
mated percentage of eligible patients, i.e. 66%. We had
estimated that 40% of all eligible patients would be ran-
domised; site 1 randomised 32% and site 3 randomised
19% of eligible patients. Site 2, in contrast, randomised
45% of eligible patients. Why sites did not manage toTable 1 Revised estimated and actual admission, eligibility an
Site 1 Site 2 Site
Estimated Actual Estimated Actual Esti
Admissions 74 58 134 58 125
Eligible
(% of admissions)
49 (66%) 40 (69%) 88 (66%) 40 (69%) 82 (
Randomised
(% of eligible patients)
20 (40%) 13 (32%) 35 (40%) 18 (45%) 33 (meet their estimated recruitment target is explained in
the following sections.
Stage 1: Assessing patients for eligibility
Table 2 shows that the research nurse in site 3 assessed
65% of patients for eligibility, whereas the clinical nurse
specialists at the other two sites reached more patients,
assessing 86% and 91% of all patient admissions, respect-
ively. Although for the purposes of trial we wanted every
patient formally assessed and the reasons for ineligibility
reported, the research nurse at site 3 said during one of
the monthly research team meetings that she had delib-
erately only assessed those patients whom she knew
were most likely to be eligible and had avoided those she
was almost certain would not meet eligibility criteria.d consent rates in each site
3 All sites
mated Actual Original estimate Revised estimated Actual
82 250 333 198
66%) 53 (65%) 165 (66%) 219 (66%) 133 (67%)
40%) 10 (19%) 66 (40%) 88 (40%) 41 (31%)
Table 2 Recruitment activity for each site
Site 1 Site 2 Site 3 All sites
Admissions (1 January to 31 July 2014) 58 58 82 198
Stage 1: Assessing patients for eligibility
Assessed for eligibility Proportion of patient admissions (n = 58, 58, 82) 50 86% 53 91% 53 65% 156 79%
Number of eligible patients Proportion of patient admissions (n = 50, 53, 53) 40 67% 40 67% 53 65% 133 67%
Stage 2: Screening forms
Screening forms for eligible patients Proportion of eligible patients (n = 40, 40, 53) 32 80% 31 78% 37 70% 100 75%
Consented to be approached by researcher Proportion of screening forms (n = 32, 31, 37) 23 72% 23 74% 28 76% 74 74%
Declined to participate Proportion of screening forms (n = 32, 31, 37) 9 28% 8 26% 8 21% 25 25%
Ineligible Proportion of screening forms (n = 32, 31, 37) 0 0% 0 0% 1 3% 1 1%
Stage 3: Randomisation
Randomised Proportion consenting to be approached (n = 23, 23, 28) 13 56% 18 78% 10 37% 41 55%
Withdrew before consent/randomisation Proportion consenting to be approached (n = 23, 23, 28) 8 35% 5 22% 14 50% 27 36%
Withdrawn because would not complete cardiac rehabilitation within timescale Proportion consenting
to be approached (n = 23, 23, 28)
0 0% 0 0% 3 11% 3 4%
Not able to be contacted successfully Proportion consenting to be approached (n = 23, 23, 28) 2 9% 0 0% 1 3% 3 4%
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lost to the study at this stage of the recruitment process
at site 3 than at sites 1 and 2. How much of a difference
to recruitment formally assessing more patients for eli-
gibility at site 3 would have made is debatable as the
proportion of admissions that were eligible was almost
identical across the three sites (67%, 67% and 65%,
respectively).
Nurses at sites 1 and 2 recorded the reasons why pa-
tients were considered ineligible (N.B. this informationFigure 2 Estimated versus actual recruitment rate across all three sites.was not collected at site 3). Table 3 shows that the main
reason why patients were considered to be ineligible was
poor mobility. The table shows that over half (57%) of
patients were excluded because of poor mobility or other
clinical reasons. When these reasons are mapped to the
exclusion criteria listed in the ‘Participants’ section, it is
clear that the main reason for ineligibility is criterion 2,
i.e. ‘Patients who fail clinical/risk assessment for rehabili-
tation and are deemed unsafe to participate in exercise
classes’.
Figure 3 Site 1 revised estimated and actual recruitment rate.
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Table 2 above shows that screening forms were completed
for 75% of all eligible patients across the three sites. Table 4
shows the reasons why screening forms were not com-
pleted at the three sites.
At site 3, 30% of eligible patients did not complete a
screening form because the research nurse judged that it
would be unlikely that the patient would be able to start
the intervention (i.e. cardiac rehabilitation) within the al-
located time period of the study. The protocol states that
patients could attend cardiac rehabilitation 6 weeks
post-laparoscopic and 8 weeks post-open surgery. Pa-
tients could attend cardiac rehabilitation while they were
receiving adjuvant therapy, but at site 3, the research
nurse and/or patient did not think that they would be
able to simultaneously manage adjuvant therapy and ex-
ercise. Completing a screening form for these patients
was therefore perceived as an inappropriate use of theFigure 4 Site 2 revised estimated and actual recruitment rate.research nurse and patient time because the patient was
unlikely to be entered into the study.Stage 3: Randomisation
Table 2 shows that 25% of eligible patients completing a
screening form did not agree to participate across the
three sites. The table also shows that during stage 3,
35%, 22% and 50% of patients who initially had indicated
on the screening form that they were interested in par-
ticipating did not agree to participate in the study at
sites 1, 2 and 3, respectively.
Table 5 shows the reasons why patients did not agree to
participate at stages 2 and 3. The most common reasons
(40%) fell into the clinical category, which included poor
recovery from surgery, co-morbidity or receiving adjuvant
therapy. At sites 2 and 3, at least half of eligible patients
cited clinical reasons for non-participation compared to
Figure 5 Site 3 revised estimated and actual recruitment rate.
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remote and rural areas.
Discussion
Recruitment is frequently the most difficult task in con-
ducting an RCT [35]. Calls for public reporting of re-
cruitment performance for each site within a trial, not
just overall recruitment [35], will improve transparency
but will not necessarily improve recruitment. Under-
standing barriers and developing interventions to im-
prove recruitment are also required.
System-level barriers to recruitment include research,
ethical and management approvals, which have been
found to have a detrimental impact on recruitment in tri-
als [16,17,20]. Although we did not encounter problems in
obtaining NHS ethical committee approval, we did experi-
ence problems with NHS Research Management approval
at two of the three sites. We found inconsistencies be-
tween sites for obtaining Research Management approvals.
For example, one research manager insisted that all con-
tracts between universities where grant holders were
employed must be signed before NHS Research and Man-
agement approval could be granted. A single Research andTable 3 Reasons for ineligibility (sites 1 and 2)
Reason given by nurse Number of patients Exclusion criteria
(1–3)a
Poor mobility 8 (35%) 2
Other clinical reason 5 (22%) 2
Advanced disease 2 (9%) 1
Unable to provide consent 3 (13%) 3
Patient is a full-time carer 1 (4%) N/A
Unknown 4 (17%) N/A
Percentages are the proportion of ineligible patients at sites 1 and 2, n = 23.
N/A not applicable.
aSee ‘Participants’ section.Management approval system and guidance for researchers
and research managers may contribute towards easing the
process. In addition, face-to-face communication be-
tween the research team and the NHS Research and
Development office may also help avoid delays in
obtaining NHS Research and Management approval.
Many reasons for low levels of recruitment have been
cited in the literature, including fewer eligible patients
than expected and a smaller percentage of patients actu-
ally agreeing to participate than originally estimated
[15,44]. Recruitment estimates can be used to monitor
recruitment performance, and therefore, it is helpful to
get estimates as accurate as possible. This is why it is
sometimes helpful to revise estimates if more robust
data to inform estimates are obtainable. Our experience
suggests that obtaining the number of patient admis-
sions is not as straightforward as it seems. For instance,
our original estimate that we used in the protocol dif-
fered from our revised estimate. More importantly, the
actual number of patient admissions during the recruit-
ment period differed from both of these estimates. Trial-
ists can make recruitment estimates based on the
literature, routine administrative data and experience; by
conducting feasibility and pilot work, a trialist hopes to
improve these estimates. It is important that this as-
sumption of improved estimates is a good one becauseTable 4 Reasons why a screening form was not
completed
Reason Site 1 Site 2 Site 3
Early discharge or moved wards 4 (10%) 5 (12%) 0 (0%)
Refused to have information kept 4 (10%) 4 (10%) 0 (0%)
Patient could not be consented in
time to start intervention
0 (0%) 0 (0%) 16 (30%)
Percentages are the proportion of eligible patients (site 1 n = 40, site 2 n = 40,
site 3 n = 53).
Table 5 Reasons for declining to participate
Reason Site 1 Site 2 Site 3 All sites
No longer eligible 2 (11.5%) - 2 (9%) 4 (7%)
Distance/travel barriers 7 (41%) - 2 (9%) 9 (17%)
Perceived as already exercising and fit 3 (18%) 2 (15%) 1 (4%) 6 (12%)
Clinical, e.g. poor recovery from surgery, receiving adjuvant therapy, co-morbidity 3 (18%) 7 (54%) 11 (50%) 21 (40%)
Too much of a commitment - - 3 (14%) 3 (6%)
Not/no longer interested 2 (11.5%) 4 (31%) - 6 (12%)
No reason given - - 3 (14%) 3 (6%)
Percentages are of the proportion of patient refusals (site 1 n = 17, site 2 n = 13, site 3 n = 22).
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Dickson and colleagues, for instance, conducted a pilot
trial in two sites but in the main trial still encountered
recruitment problems due to fewer eligible women pre-
senting to participating clinics than predicted [20].
McDonald and colleagues found that trials having pilot
phases, in many cases, changed their recruitment strat-
egies as a result of them. Despite this, they found no dif-
ference in recruitment success between trials having a
pilot phase and those that did not [8]. If preliminary
studies are only used to improve estimates and little effort
is expended in understanding barriers and facilitators to
recruitment, then any future trial may nevertheless en-
counter recruitment difficulties.
A pilot trial is particularly useful in pinpointing where
in the recruitment pathway barriers to participation are
most likely to occur. Our pilot trial, for instance, sug-
gests that stage 3 (consenting and randomisation) was
where most participants were lost to the study. It seems
reasonable therefore to focus on the part of the pathway
where most patients are lost to the study. However, re-
cruitment is best conceived as a whole system with
inter-related discrete stages and processes. Any change
in an earlier part of the system will have a knock-on ef-
fect on other parts. It may be more productive, there-
fore, to focus attention on earlier stages, i.e. stages 1
(screening for eligibility) and 2 (participant agreeing to
be involved and contacted by a researcher), in order to
improve recruitment in stage 3 (consenting and random-
isation). Understanding recruitment as a process rather
than a singular event was highlighted at a recent trial re-
cruitment workshop [45].
Studies have consistently shown that clinicians have
a significant impact on recruitment performance
[14,17,23-26]. Training of clinical recruiters may im-
prove recruitment rates [46]. The literature does not
refer to behaviour models or theories to understand or
explain recruitment performance, preferring instead to
highlight factors such as lack of time [24,47]. Behav-
ioural theories may contribute towards understanding
recruitment performance. In social cognitive theory,
for instance, ‘outcome expectations’ reflect individuals’beliefs about what consequences are most likely to en-
sue if particular behaviours are performed [48]. Ap-
plied to recruitment, the theory suggests that clinicians
may not adhere to recruitment protocols if they believe
that it will not actually make a difference to the re-
cruitment rate. Our pilot trial shows that the research
nurse at site 3 only assessed those patients who she
knew were likely to be eligible and did not formally as-
sess those who she believed would not be eligible,
which suggests that she did not implement research
procedures that she believed would not affect the over-
all recruitment rate of the study. Additionally, she did
not complete a screening form for those patients who
would be having adjuvant therapy and therefore unable
to attend cardiac rehabilitation. The general point we
are making is that recruitment is not simply a practical
venture necessitating practical solutions to improve re-
cruitment performance (e.g. addressing lack of time)
but requires understanding and addressing the behav-
iour (e.g. assessing outcomes expectancies) of both
staff and patients.
Few studies have examined differences in recruitment
by health profession [17]. We found that clinical practice
nurses assessed more patients for eligibility than a re-
search nurse did. Nurses possibly know patients better
than research nurses because they are providing care
and it may be that nurses can assess patients for eligibil-
ity very quickly, without recourse to reading medical
notes or speaking with the patient. Needless to say, it is
difficult to draw a definitive conclusion about differences
in recruitment by profession from such a small study,
and further research examining recruitment perform-
ance by profession is required.
The literature has highlighted patient barriers to re-
cruitment [31,17]. An important issue to emerge in our
study was the need to look at issues to do with recruit-
ment at a site-specific level because barriers to recruit-
ment vary across sites. Conducting a pilot trial in a small
number of sites with a range of features considered rele-
vant to recruitment may be useful in pre-empting com-
mon and unique patient barriers within different
contexts. The pilot trial, for instance, suggests that only
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travel factors as a barrier to recruitment but that all sites
are likely to experience poor recovery and ongoing treat-
ment as patient barriers to participation. The importance
of context for understanding the conduct and outcomes
of trials has been recognised in other research [49,50].
Ongoing monitoring and evaluation could be conducted
in a small number of sites representative of other sites
with shared characteristics on the assumption that re-
cruitment barriers and therefore solutions will be applic-
able to those sites with common characteristics and
similar contexts. This may be a more cost-effective solu-
tion than ongoing evaluation and monitoring in every
single site in a larger trial.
There are common barriers to recruitment [13-19],
and awareness of these should help trialists to develop
strategies to address typical barriers. Nevertheless, rea-
sons for poor recruitment, and thereby strategies for im-
proving recruitment, will vary from one trial to the next.
One trial, for instance, reported poor clinician ‘buy in’ as
a factor impeding recruitment [51], whereas this was not
an issue that we encountered in our pilot trial. Another
trial cited protocol issues as the main reason for poor
participation [52], whereas our pilot trial identified clin-
ical (e.g. poor recovery from surgery, receiving adjuvant
therapy, co-morbidity) and distance/travel issues as the
main reasons for refusal. This is why it is important to
continuously and closely monitor recruitment and use
qualitative methods to identify and then rectify problems
through the use of tailored interventions [2,4,12,53].
Strengths and limitations
This pilot trial shows system- and individual-level fac-
tors impacting recruitment of patients with bowel cancer
to a pilot RCT of cardiac rehabilitation. Caution is re-
quired when interpreting these findings because they are
drawn from a small pilot trial involving only three sites.
There is inevitably a limit to the generalisability of these
findings beyond this particular population, intervention
and study design. Furthermore, even equivalent popula-
tion and intervention trials are unlikely to face identical
barriers because of the influence of contextual factors
[22]. In other words, generalisability will always be lim-
ited. Nevertheless, there may be common methods that
trialists can adopt to improve recruitment, including the
careful use of pilot trials and ongoing monitoring and
evaluation of recruitment performance.
Conclusions
Pilot trials should not simply aim to improve recruit-
ment estimates but should also identify factors likely to
influence recruitment performance in a future large-
scale trial and inform the development of that trial’s re-
cruitment strategies. Pilot trials are a crucial part ofRCT design and should be fully supported and funded.
Nevertheless, pilot trials are likely to be small scale, in-
volving only a small number of sites, and contextual dif-
ferences between sites are likely to impact recruitment
performance in any future trial. This means that factors
impacting recruitment ought to be examined at a site-
specific level. This means that ongoing monitoring and
evaluation in effectiveness trials are likely to be required.
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